Tokyo (JCN) Dec 6, 2005 - Ono Pharmaceutical and Dainipopn Sumitomo Pharma jointly announced on December 6 that they have singed a joint development and marketing agreement for limaprost alfadex, an oral prostaglandin E1 derivative indicated for the treatment of peripheral circulatory disturbance.
